PureTech Health plc announced that as noted in PureTech's 2022 half-year report, Dame Marjorie Scardino, Senior Independent Director, chair of the Nomination Committee and member of the Audit Committee, will retire as of the close of business on December 31, 2022. Raju Kucherlapati, Ph.D., will assume the role of PureTech's Senior Independent Director as well as the chair of its Nomination Committee, effective as of Dame Scardino's retirement. Christopher Viehbacher, Chair of PureTech's Board, was recently appointed President, Chief Executive Officer and a member of the Board of Biogen Inc. Given the time commitment required by this new role, Mr. Viehbacher will not stand for re-election at the Company's 2023 Annual General Meeting.

The Nomination Committee will initiate a process to identify a new Chair.